Dna Group (T.R.) Ltd (TLV:DNA)

Dna Group (T.R.) Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0.31	0.31	0.31	0.56	-	-
Revenue Growth (YoY)	-	-	-45.36%	-	-	-
Gross Profit	0.31	0.31	0.31	0.56	-	-
Selling, General & Admin	1.6	1.82	2.48	6.26	2.37	1.59
Operating Expenses	1.6	1.82	2.48	6.26	2.37	1.59
Operating Income	-1.3	-1.51	-2.17	-5.7	-2.37	-1.59
Interest Expense	-	-	-	-	-	-0
Interest & Investment Income	2.2	2.79	1.88	0.35	-	-
Earnings From Equity Investments	1.58	1.39	0.23	1.24	1.49	-14.66
Currency Exchange Gain (Loss)	0	0	0.35	0.49	-	-
Other Non Operating Income (Expenses)	-	-	-	-0.04	7.59	-1.16
EBT Excluding Unusual Items	2.49	2.67	0.29	-3.67	6.71	-17.41
Gain (Loss) on Sale of Investments	-1.9	20.74	-1.47	-19.87	11.67	-1.85
Pretax Income	0.58	23.4	-1.18	-23.54	18.37	-19.27
Income Tax Expense	0.07	1.31	-	-	-	-
Earnings From Continuing Operations	0.52	22.1	-1.18	-23.54	18.37	-19.27
Net Income to Company	0.52	22.1	-1.18	-23.54	18.37	-19.27
Net Income	0.52	22.1	-1.18	-23.54	18.37	-19.27
Net Income to Common	0.52	22.1	-1.18	-23.54	18.37	-19.27
Shares Outstanding (Basic)	123	123	123	117	87	30
Shares Outstanding (Diluted)	123	123	123	117	88	30
Shares Change (YoY)	0.01%	0.03%	5.65%	32.13%	189.68%	21.91%
EPS (Basic)	0.00	0.18	-0.01	-0.20	0.21	-0.63
EPS (Diluted)	0.00	0.18	-0.01	-0.20	0.21	-0.63
Free Cash Flow	2.04	1.61	-0.68	-0.35	-2.33	-0.61
Free Cash Flow Per Share	0.02	0.01	-0.01	-0.00	-0.03	-0.02
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-424.18%	-493.46%	-710.46%	-1017.68%	-	-
Profit Margin	168.63%	7220.91%	-384.64%	-4202.86%	-	-
Free Cash Flow Margin	665.36%	526.14%	-221.57%	-63.21%	-	-
EBIT	-1.3	-1.51	-2.17	-5.7	-2.37	-1.59
Effective Tax Rate	11.64%	5.58%	-	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.